Gilead: Gilead Partners With Startup Getting Its Tentacles Into New Biologic Drug Territory
Gilead Sciences is partnering with Tentarix Biotherapeutics, a startup developing multifunctional antibody drugs that it calls "Tentacles." Tentarix's technology offers the potential to selectively address targets in cancer and inflammation.
Read full article »
Gilead is a California-based biopharmaceutical company that develops and commercializes antiviral drugs for a wide range of diseases.
Read more